A detailed history of Farallon Capital Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,319 shares of MDGL stock, worth $722,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,319
Holding current value
$722,845
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$120.4 - $237.13 $399,607 - $787,034
3,319 New
3,319 $767,000
Q3 2023

Nov 14, 2023

BUY
$146.04 - $225.78 $484,706 - $749,363
3,319 New
3,319 $484,000
Q2 2023

Aug 14, 2023

SELL
$203.88 - $312.0 $32.7 Million - $50.1 Million
-160,500 Reduced 97.97%
3,319 $766,000
Q1 2023

May 15, 2023

BUY
$231.06 - $307.08 $2.5 Million - $3.32 Million
10,819 Added 7.07%
163,819 $39.7 Million
Q4 2022

Feb 14, 2023

BUY
$58.39 - $296.54 $8.93 Million - $45.4 Million
153,000 New
153,000 $44.4 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.72B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.